Implication of Complement System and its Regulators in Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|7|1|1-8

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.7, Iss.1, 2009-03, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimer's Disease, Depression, and Parkinson's Disease

By  

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 57-66

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's disease: Targeting the Cholinergic System

By  

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 101-115

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's disease: neurochemistry of Alzheimer's disease and its clinical implications

By Amaducci L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 204-204

Elsevier

Access to resources Recommend Favorite

Complement components of the innate immune system in health and disease in the CNS

By Gasque P.   Dean Y.D.   McGreal E.P.   VanBeek J.   Morgan B.P.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 171-186

Elsevier

Access to resources Recommend Favorite

Donepezil: a guide to its use in Alzheimer's disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 9, 2009-09 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite